Integra lifesciences holdings corp (IART)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Revenue from Contract with Customer, Excluding Assessed Tax

1,512,191

1,517,557

1,505,745

1,492,504

1,475,049

1,472,441

1,457,728

1,370,708

1,286,682

1,188,236

1,075,298

1,046,796

1,013,941

992,075

977,571

953,606

916,970

882,734

794,358

765,514

784,192

796,717

725,320

741,043

715,239

696,832

829,877

826,715

831,338

830,871

819,962

812,063

795,222

780,078

770,689

755,145

740,411

732,068

710,220

689,304

0

0

0

Costs and expenses:
Cost of goods sold

569,245

564,681

561,683

562,292

556,186

571,496

573,203

531,715

493,148

435,511

372,762

360,334

350,901

349,089

353,668

350,408

336,094

326,542

296,232

284,059

295,784

302,946

279,595

287,466

282,319

279,548

325,138

322,919

319,364

314,427

315,237

314,340

308,904

299,150

287,716

278,259

269,885

268,188

259,903

250,514

0

0

0

Research and development

82,068

79,573

75,256

76,562

78,037

78,041

74,922

69,647

66,286

63,455

60,176

60,266

59,198

58,155

58,120

56,934

54,267

50,895

43,142

40,338

42,071

43,559

42,491

44,409

42,473

42,622

50,441

50,494

51,816

51,012

51,550

51,632

51,210

51,451

51,380

49,914

48,966

48,114

46,308

44,889

0

0

0

In-process research and development

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

678,681

687,599

690,574

690,831

702,050

690,746

704,157

676,747

645,165

624,096

545,577

511,949

486,151

455,629

453,259

454,366

434,467

415,757

364,173

344,537

360,472

375,545

343,532

349,538

337,565

332,190

402,566

395,849

388,666

373,114

371,393

365,824

365,459

358,132

345,914

334,144

312,628

305,055

292,380

284,894

0

0

0

Intangible asset amortization

28,726

27,028

26,555

26,767

21,049

21,160

21,338

21,526

21,659

20,370

18,429

16,440

14,492

13,862

13,944

13,419

11,695

9,953

5,612

4,268

5,506

6,810

5,055

6,493

6,581

7,099

14,211

15,793

17,367

18,536

18,809

18,739

18,142

16,433

14,353

12,484

12,009

12,017

13,278

14,060

0

0

0

Goodwill impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

1,423,636

1,423,797

1,413,957

1,356,452

1,357,322

1,361,443

1,373,620

1,299,635

1,226,258

1,143,432

996,944

948,989

910,742

876,735

878,991

875,127

836,523

803,147

709,159

673,202

703,833

728,860

623,935

687,906

668,938

661,459

839,094

785,055

777,213

757,089

756,989

750,535

743,715

725,166

699,363

674,801

643,488

633,374

611,869

594,357

0

0

0

Operating income

88,555

93,760

91,788

136,052

117,727

110,998

84,108

71,073

60,424

44,804

78,354

97,807

103,199

115,340

98,580

78,479

80,447

79,587

85,199

92,312

80,359

67,857

101,385

53,137

46,301

35,373

-9,217

41,660

54,125

73,782

62,973

61,528

51,507

54,912

71,326

80,344

96,923

98,694

98,351

94,947

0

0

0

Interest income

10,921

10,779

10,526

7,688

5,152

2,800

420

434

324

255

170

83

25

24

26

29

31

30

41

61

111

168

4,688

4,701

4,932

4,933

702

764

890

1,205

1,004

1,058

770

465

407

312

237

225

369

444

0

0

0

Interest expense

58,560

53,957

54,428

54,944

59,064

64,683

67,696

59,979

48,656

35,019

24,620

24,154

24,561

25,803

25,369

25,538

24,435

23,534

22,952

22,400

22,297

21,967

21,080

20,484

20,067

19,725

16,737

16,970

19,108

22,237

28,443

30,481

30,100

27,640

24,903

21,706

19,284

18,356

18,724

20,508

0

0

0

Other income(expense), net

5,807

9,522

10,327

7,950

9,279

8,288

11,458

8,973

3,680

1,345

-2,448

-521

1,493

845

1,206

1,841

1,833

4,588

2,320

230

1,208

-492

-79

-79

-504

-1,795

-2,147

-1,915

-1,372

-721

260

720

1,077

757

728

-408

-238

1,551

822

1,048

0

0

0

Income before income taxes

46,723

60,104

58,213

96,746

73,094

57,403

28,290

20,501

15,772

11,385

51,456

73,215

80,156

90,406

74,443

54,811

57,876

60,671

64,608

70,203

59,381

45,566

84,914

37,275

30,662

18,786

-27,399

23,539

34,535

52,029

35,794

32,825

23,254

28,494

47,558

58,542

77,638

82,114

80,818

75,931

0

0

0

Provision (benefit) for income taxes

20,098

9,903

-1,807

-4,179

-9,471

-3,398

-51,728

-49,381

-53,569

-53,358

2,822

7,596

12,617

15,842

13,145

45,538

49,338

53,820

52,463

17,187

13,560

9,271

12,028

3,709

401

-3,241

-5,347

2,050

6,052

10,825

2,816

1,815

59

505

5,322

11,066

15,704

16,445

19,524

19,895

0

0

0

Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations (net of tax benefit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,370

-9,553

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income

26,625

50,201

60,020

100,925

82,565

60,801

80,018

69,882

69,341

64,743

48,634

65,619

67,539

74,564

61,298

9,273

1,516

-3,519

-1,333

40,355

40,182

34,004

30,609

-9,528

-12,833

-21,067

-22,052

21,489

28,483

41,204

32,978

31,010

23,195

27,989

42,236

47,476

61,934

65,669

61,294

56,036

0

0

0

Net income per share
Income from continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.28

-0.90

0.36

0.36

-

0.28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-0.21

-0.10

-

0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in dollars per share)

0.11

0.18

-0.32

0.35

0.38

0.29

0.16

0.14

0.14

0.57

0.04

0.14

0.09

0.38

0.27

0.17

0.18

0.44

-0.90

0.15

0.26

-0.01

0.31

0.15

0.07

0.52

-1.09

0.05

-0.22

0.46

0.46

0.30

0.24

0.17

0.39

0.02

0.39

0.63

0.56

0.51

0.51

0.49

0.38

Income from continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.30

-0.90

0.35

0.35

-

0.27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-0.21

-0.10

-

0.02

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.11

0.18

-0.32

0.34

0.38

0.29

0.15

0.14

0.14

0.56

0.04

0.14

0.08

0.35

0.25

0.16

0.18

0.46

-0.90

0.14

0.25

0.01

0.29

0.15

0.07

0.52

-1.09

0.05

-0.22

0.45

0.46

0.30

0.23

0.16

0.39

0.02

0.38

0.62

0.55

0.50

0.50

0.49

0.38

Weighted average common shares outstanding (See Note 13):
Basic (in shares)

85,188

85,940

85,688

85,577

85,343

85,260

85,193

82,423

78,552

78,424

78,186

76,213

74,765

74,684

74,534

74,392

73,934

174,913

35,279

33,032

32,736

162,333

32,450

32,398

32,275

30,099

27,896

27,873

27,796

27,718

28,446

28,419

28,345

28,107

28,583

29,556

29,562

29,277

29,572

29,855

29,488

29,049

29,004

Diluted (in shares)

85,892

87,773

85,688

86,257

86,258

86,350

86,299

83,513

79,834

79,672

79,455

78,963

78,394

80,568

81,032

78,710

76,466

182,856

35,279

33,939

33,342

165,202

32,906

32,804

32,768

31,398

27,896

28,118

27,796

28,190

28,777

28,609

28,488

28,588

29,029

30,178

30,185

30,143

30,072

30,399

29,982

29,400

29,202

Comprehensive income (loss) (See Note 14)

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-